Concept Medical Group recognized among India's top 30 Mid-Size Best Workplaces in manufacturing 2026
PNN
Surat (Gujarat) [India], February 2: Concept Medical Group, comprising Envision Scientific Pvt. Ltd. and Concept Medical Research Pvt. Ltd., has been recognized among the Top 30 mid-size manufacturing companies in India in India's Best Workplaces™ in Manufacturing 2026. This Great Place To Work® recognition highlights organizations that successfully balance manufacturing excellence with a high-trust, high-performance workplace culture.
This milestone reflects the Group's people-first philosophy and its continued focus on building a workplace rooted in trust, collaboration, innovation, and accountability. The recognition highlights the organization's ability to inspire trust, instill pride, and foster camaraderie, creating an employee experience where people can do their best work and grow with purpose.
About Concept Medical Group
Concept Medical Group is a global medical technology group advancing coronary and peripheral vascular care through patented, nanocarrier-based drug-delivery platforms. Headquartered in Tampa, Florida, the Group pioneered MagicTouch™ the world's first commercially available sirolimus-coated balloon (SCB) built on the proprietary Nanolute™ platform and offers a growing portfolio of drug-coated balloons and polymer-free drug-eluting stents. With a commercial presence in 80+ countries, its technologies have treated more than one million patients worldwide. Concept Medical's evidence base spans 45+ clinical trials involving 24,000+ patients, including completed studies in Japan; MagicTouch holds CE Mark approval, U.S. FDA Breakthrough Device Designation, and five U.S. FDA IDE approvals across coronary and peripheral indications. Envision Scientific, the Group's large-scale manufacturing platform in India, is ESG-certified, IGBC Gold-rated and ISO-certified, operates under systems compliant with key global regulators including PMDA (Japan), and has the capacity to produce over one million drug-delivery devices annually. The Group is committed to expanding indications and improving outcomes for patients globally.
Next Story